<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33799036</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2517</ISSN><JournalIssue CitedMedium="Internet"><Volume>287</Volume><PubDate><Year>2021</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of affective disorders</Title><ISOAbbreviation>J Affect Disord</ISOAbbreviation></Journal><ArticleTitle>Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: A systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>182</StartPage><EndPage>190</EndPage><MedlinePgn>182-190</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2021.03.015</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0165-0327(21)00240-8</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) people have a high risk of severe mental disorders, like depression, which impacts their function, quality of life, and mobility. However, there are no estimates of depression based paper published. This study aimed conduct a systematic review and meta-analysis of the prevalence of depression in ALS patients around the world.</AbstractText><AbstractText Label="METHODS">PubMed/Medline, Web of science, Scopus, Embase, and Ovid are searched to identify papers that reporting the prevalence of depression. Studies are included in random-effects meta-analyses of the prevalence of depression. Subgroup analyses are performed on the severity of depression, instruments of depression, type of studies, and study regions.</AbstractText><AbstractText Label="RESULTS">46 eligible studies reported prevalence of depression. The pooled prevalence of depression among ALS people was 34% (27%-41%). According to the severity of depression, mild, moderate, and severe depression were 29%, 16%, and 8%, respectively. For studies using BDI, PHQ, and HADS, the pooled prevalence of depression was 50%, 20%, and 15%, respectively.</AbstractText><AbstractText Label="CONCLUSIONS">ALS people have a high prevalence of depression. The high prevalence of depression causes a reduction of quality of life and mobility. The study identifies a population group at high risk needing special attention in clinical practice.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Heidari</LastName><ForeName>Mohammad Eghbal</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Student 's scientific research center, Tehran University of Medical Sciences, Theran, Iran. Electronic address: mohammad.eghbal.heydari@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nadali</LastName><ForeName>Javad</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>School of Nursing and Midwifery, Shahroud University of Medical Sciences, Shahroud, Iran. Electronic address: jnadali@alumnus.tums.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parouhan</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Student 's scientific research center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Theran, Iran. Electronic address: Ali_paroohan@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Azarafraz</LastName><ForeName>Mahdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Young Researchers Elite Club, Islamic Azad University Tehran Medical Branch, Tehran, Iran. Electronic address: azarafrazmahdi@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tabatabai</LastName><ForeName>Seyed Mohamadhasan</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Young Researchers Elite Club, Islamic Azad University Tehran Medical Branch, Tehran, Iran, Theran, Iran. Electronic address: hasantabatabai2000@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irvani</LastName><ForeName>Seyed Sina Naghibi</ForeName><Initials>SSN</Initials><AffiliationInfo><Affiliation>Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: Irvani@sbmu.ac.ir.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eskandari</LastName><ForeName>Fereshte</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Student 's scientific research center, School of Nursing and Midwifery, Tehran University of Medical Sciences, Theran, Iran. Electronic address: 8238fereshte.eskandari@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gharebaghi</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran. Electronic address: Ar.gharebaghi@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>J Affect Disord</MedlineTA><NlmUniqueID>7906073</NlmUniqueID><ISSNLinking>0165-0327</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="Y">Depressive Disorder</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Als</Keyword><Keyword MajorTopicYN="N">Depression</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>20</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33799036</ArticleId><ArticleId IdType="doi">10.1016/j.jad.2021.03.015</ArticleId><ArticleId IdType="pii">S0165-0327(21)00240-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>